Lung cancer
Therapeutic area
Oncology
Rare disease
No
- Definition
- A malignant neoplasm involving the lung.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Lung cancer
- Therapeutic area
- Oncology
- lung cancer
- adenocarcinoma of lung, response to tyrosine kinase inhibitor in, autosomal dominant, somatic mutation
- adenocarcinoma of lung, somatic
- cancer of lung
- lung cancer
- lung cancer, protection against, autosomal dominant, somatic mutation
- lung cancer, resistance to, autosomal dominant, somatic mutation
- lung cancer, somatic
- lung cancer, susceptibility to, autosomal dominant, somatic mutation
- malignant lung neoplasm
- malignant lung tumor
- malignant lung tumour
- malignant neoplasm of lung
- malignant neoplasm of the lung
- malignant tumor of lung
- malignant tumor of the lung
- malignant tumour of lung
- malignant tumour of the lung
- nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, autosomal dominant, somatic mutation
- nonsmall cell lung cancer, somatic
- nonsmall cell lung cancer, susceptibility to, autosomal dominant, somatic mutation
- Severity
- Severe
- Oncology
- Pulmonology
- MONDO ID
- MONDO:0008903
- Parent condition
- MONDO:0000376
Related records
Broader conditions (16)
- Cancer
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Human disease
- Lower respiratory tract disorder
- Lung disorder
- Lung neoplasm
- Neoplasm
- Neoplasm of thorax
- Neoplastic disease or syndrome
- Respiratory system cancer
- Respiratory system disorder
- Respiratory tract neoplasm
- Thoracic cancer
Narrower conditions (63)
- Acinar lung adenocarcinoma
- Adenosquamous lung carcinoma
- Asbestos-related lung carcinoma
- Basaloid large cell lung carcinoma
- Bronchogenic carcinoma
- Bronchus carcinoma in situ
- Bronchus mucoepidermoid carcinoma
- Classic pulmonary blastoma
- Combined lung carcinoma
- Combined small cell lung carcinoma
- Epithelial predominant pulmonary blastoma
- Fetal lung interstitial tumor
- Graham-Boyle-Troxell syndrome
- Large cell carcinoma with rhabdoid phenotype
- Large cell lung carcinoma, clear cell variant
- Lung adenocarcinoma
- Lung adenocarcinoma in situ
- Lung adenoid cystic carcinoma
- Lung carcinoma
- Lung carcinoma in situ
Trials (3,603)
- 'Lung Health Check' Biomarker Study
- "Impact of a Nursing Intervention in the Management of Oncological Patients With Lung Cancer Under Treatment With Immunotherapy"
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
- [18F]HX4 PET/CT Imaging for Detection of Hypoxia
- 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
- 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
- 11C Topotecan PET Imaging
- 11C-Acetate PET/CT Non-FDG-Avid Tumors
- 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
- 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
- 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer
- 18F-FAPI PET in Lung Cancer
- 18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer
- 19F Thoracic Radiotherapy for Lung Cancer
- 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
- 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
- 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy
- 3D Lung Reconstructions Using Open-source Software for Lung Cancer Surgery
- 3D Printing for Nodule Localization
Approved drugs (5)
- Atezolizumab
- Cemiplimab
- Etoposide
- Methotrexate sodium
- Trametinib dimethyl sulfoxide
Drugs in development (332)
- 7-ethyl-10-hydroxycamptothecin Phase 2
- 9-aminocamptothecin Phase 2
- Abemaciclib Phase 2
- Acridine Phase 2
- Adagrasib Phase 1
- Adavosertib Phase 2
- Afatinib Phase 2
- Agatolimod Phase 2
- Aldesleukin Phase 2
- Allitinib Phase 2
- Amifostine Phase 3
- Amivantamab Phase 1
- Amrubicin Phase 3
- Amrubicin hydrochloride Phase 3
- Antineoplaston A10 Phase 2
- Apatorsen Phase 2
- Arsenic trioxide Phase 2
- Ascorbic acid Phase 2
- Aumolertinib Phase 3
- Batabulin sodium Phase 2
Other linked drugs (12)
- Alectinib
- Dacomitinib
- Dexmedetomidine
- Ethiodized oil
- FISH OIL
- Gebasaxturev
- L-DOS47
- Nefopam
- Olmutinib
- Pemlimogene merolisbac
- Plicamycin
- Plinabulin